|18.71||+0.4100||+2.24%||Vol 363.50K||1Y Perf 195.08%|
|Apr 13th, 2021 16:00 DELAYED|
|- -||- -%|
|Target Price||16.00||Analyst Rating||Strong Buy 1.00|
|Potential %||-14.48||Finscreener Ranking||★★ 46.10|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★ 52.01|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★+ 38.87|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Market Cap||529.51M||Earnings Rating||Strong Sell|
|Price Range Ratio 52W %||62.05||Earnings Date||29th Apr 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||29th Apr 2021|
|Estimated EPS Next Report||-0.18|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||189.73K|
|Avg. Monthly Volume||250.13K|
|Avg. Quarterly Volume||275.43K|
Aspen Aerogels Inc. (NYSE: ASPN) stock closed at 18.71 per share at the end of the most recent trading day (a 2.24% change compared to the prior day closing price) with a volume of 363.51K shares and market capitalization of 529.51M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Construction industry, Industrials sector and employs 304 people. Aspen Aerogels Inc. CEO is Donald R. Young.
The one-year performance of Aspen Aerogels Inc. stock is 195.08%, while year-to-date (YTD) performance is 12.1%. ASPN stock has a five-year performance of 349.76%. Its 52-week range is between 5.19 and 26.98, which gives ASPN stock a 52-week price range ratio of 62.05%
Aspen Aerogels Inc. currently has a PE ratio of -23.90, a price-to-book (PB) ratio of 8.19, a price-to-sale (PS) ratio of 7.21, a price to cashflow ratio of 262.20, a PEG ratio of 2.32, a ROA of -20.76%, a ROC of -23.41% and a ROE of -33.02%. The company’s profit margin is -26.60%, its EBITDA margin is -4.10%, and its revenue ttm is $71.85 Million , which makes it $2.54 revenue per share.
Of the last four earnings reports from Aspen Aerogels Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.18 for the next earnings report. Aspen Aerogels Inc.’s next earnings report date is 29th Apr 2021.
The consensus rating of Wall Street analysts for Aspen Aerogels Inc. is Strong Buy (1), with a target price of $16, which is -14.48% compared to the current price. The earnings rating for Aspen Aerogels Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Aspen Aerogels Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Aspen Aerogels Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 16.86, ATR14 : 1.75, CCI20 : -143.73, Chaikin Money Flow : 0.09, MACD : -0.42, Money Flow Index : 29.01, ROC : -1.68, RSI : 45.81, STOCH (14,3) : 30.05, STOCH RSI : 0.28, UO : 38.78, Williams %R : -69.95), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Aspen Aerogels Inc. in the last 12-months were: Corby C. Whitaker (Option Excercise at a value of $1 311 427), Corby C. Whitaker (Sold 195 914 shares of value $2 647 638 ), Gregg R. Landes (Option Excercise at a value of $113 055), Gregg R. Landes (Sold 27 308 shares of value $317 046 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.